- Home
- MRUS vs ORA Comparison
MRUS vs ORA Comparison
Compare MRUS & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- ORA
- Stock Information
- Founded
- MRUS 2003
- ORA 1965
- Country
- MRUS Netherlands
- ORA United States
- Employees
- MRUS N/A
- ORA N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- ORA Electric Utilities: Central
- Sector
- MRUS Health Care
- ORA Utilities
- Exchange
- MRUS Nasdaq
- ORA Nasdaq
- Market Cap
- MRUS 4.1B
- ORA 4.6B
- IPO Year
- MRUS 2016
- ORA 2004
- Fundamental
- Price
- MRUS $66.82
- ORA $89.47
- Analyst Decision
- MRUS Strong Buy
- ORA Buy
- Analyst Count
- MRUS 13
- ORA 8
- Target Price
- MRUS $88.54
- ORA $88.75
- AVG Volume (30 Days)
- MRUS 645.9K
- ORA 518.6K
- Earning Date
- MRUS 08-04-2025
- ORA 08-06-2025
- Dividend Yield
- MRUS N/A
- ORA 0.54%
- EPS Growth
- MRUS N/A
- ORA N/A
- EPS
- MRUS N/A
- ORA 2.06
- Revenue
- MRUS $54,732,000.00
- ORA $885,250,000.00
- Revenue This Year
- MRUS $68.08
- ORA $9.65
- Revenue Next Year
- MRUS $0.09
- ORA $14.25
- P/E Ratio
- MRUS N/A
- ORA $43.37
- Revenue Growth
- MRUS 42.77
- ORA 1.95
- 52 Week Low
- MRUS $33.19
- ORA $61.58
- 52 Week High
- MRUS $67.07
- ORA $91.81
- Technical
- Relative Strength Index (RSI)
- MRUS 77.27
- ORA 64.78
- Support Level
- MRUS $61.51
- ORA $88.90
- Resistance Level
- MRUS $64.00
- ORA $91.81
- Average True Range (ATR)
- MRUS 2.32
- ORA 1.29
- MACD
- MRUS 1.02
- ORA -0.20
- Stochastic Oscillator
- MRUS 97.35
- ORA 62.62
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About ORA Ormat Technologies Inc.
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.